IDH3G Antibodies

Santa Cruz Biotechnology provides a broad selection of IDH3G monoclonal antibodies for research focused on understanding isocitrate dehydrogenase 3 gamma (IDH3G) in cellular metabolism. IDH3G monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IDH3G is a critical enzyme in the tricarboxylic acid (TCA) cycle, playing a vital role in energy production and metabolic regulation. The enzyme functions by converting isocitrate to alpha-ketoglutarate, representing a key step in cellular respiration. Research has shown that IDH3G dysregulation is linked to various metabolic disorders and cancers. Understanding IDH3G activity and regulation can provide valuable insights into cellular metabolism and disease mechanisms. Investigating IDH3G function helps researchers explore potential therapeutic strategies for metabolic disorders. Studying IDH3G expression patterns reveals important information about cellular energy production and metabolic adaptations. Santa Cruz Biotechnology monoclonal antibodies for IDH3G support researchers worldwide in advancing our understanding of cellular metabolism and its role in health and disease.